KSR1 and cancer: Moreover, in addition to the role of KSR1 itself to RAS-mediated oncogenesis and its potential as a novel anti-cancer target [78], sphingolipid dysregulation has been linked to several cardiovascular, metabolic, and neurodegenerative diseases [98,99].